Pava Partners exclusively advised Munich-based Cosinuss GmbH (“cosinuss°”) on its sale to corpuls, based in Kaufering (Bavaria), Germany.

cosinuss° has developed a globally unique technology for innovative in-ear sensors for mobile vital sign monitoring, which now expands the portfolio of corpuls, the leading manufacturer of innovative high-end devices for emergency and intensive care medicine.

As part of the corpuls family, cosinuss° can now further develop its innovative in-ear sensor for mobile vital parameter monitoring and bring it to market worldwide. The two Bavarian medical technology companies aim to jointly access new markets and enhance their innovative strength by leveraging the gained synergies. The cosinuss° location in Munich will remain unchanged. corpuls will take over all employees and continue to rely on the management team consisting of company founders Greta Kreuzer and Dr. Johannes Kreuzer.

Providing advice with technological depth—cosinuss° on Pava Partners

“Over the past years, we have been in close and continuous dialogue with Pava. This exchange has always been valuable to us—particularly regarding approval processes, international MedTech companies, and the development of our equity story. The team has an excellent understanding of the dynamics and challenges faced by rapidly growing companies. This expertise has been of great value to us,” says Dr. Johannes Kreuzer, founder and CEO of cosinuss°.